In the past, Lu et al. reported that activated Src kinases are able to alter the function of the tumor suppressor and negative regulator of the PI3K/AKT/mTOR pathway PTEN by interfering with the membrane-binding capacity of PTEN, leading to increased pAKT expression [63]. This evidence concerns the gene AKT1 and neoplasm.